Subclinical Alterations in Retinal Layers and Microvascular Structures with OCTA in ANCA-Associated Vasculitides

References

• Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol. October 14, 2016;3:122–133. doi:10.5152/eurjrheum.2015.0043.
   PubMed Web of Science ®Google Scholar
• Salvador F. ANCA associated vasculitis. Eur J Intern Med. February 02, 2020;74:18–28. doi:10.1016/j.ejim.2020.01.011.
   PubMed Web of Science ®Google Scholar
• Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. AMA Arch Pathol. December 01, 1954;58:533–553.
   PubMedGoogle Scholar
• Specks U, DeRemee RA. Granulomatous vasculitis. Wegener’s granulomatosis and Churg-Strauss syndrome. Rheum Dis Clin North Am. May 01, 1990;16:377–397. doi:10.1016/S0889-857X(21)01064-4.
   PubMed Web of Science ®Google Scholar
• Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. January 01, 1983;98:76–85. doi:10.7326/0003-4819-98-1-76.
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. March 15, 1992;116:488–498. doi:10.7326/0003-4819-116-6-488.
   PubMed Web of Science ®Google Scholar
• Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener’s granulomatosis. Ophthalmology. March 01, 1983;90:279–290. doi:10.1016/s0161-6420(83)34574-7.
   PubMed Web of Science ®Google Scholar
• Spalton DJ, Graham EM, Page NG, Sanders MD. Ocular changes in limited forms of Wegener’s granulomatosis. Br J Ophthalmol. August 01, 1981;65:553–563. doi:10.1136/bjo.65.8.553.
   PubMed Web of Science ®Google Scholar
• Kubaisi B, Abu Samra K, Foster CS. Granulomatosis with polyangiitis (Wegener’s disease): an updated review of ocular disease manifestations. Intractable Rare Dis Res. May 20, 2016;5:61–69. doi:10.5582/irdr.2016.01014.
   PubMed Web of Science ®Google Scholar
• Iida T, Spaide RF, Kantor J. Retinal and choroidal arterial occlusion in Wegener’s granulomatosis. Am J Ophthalmol. January 05, 2002;133:151–152. doi:10.1016/s0002-9394(01)01251-x.
   PubMed Web of Science ®Google Scholar
• Mirza S, Raghu Ram AR, Bowling BS, Nessim M. Central retinal artery occlusion and bilateral choroidal infarcts in Wegener’s granulomatosis. Eye (Lond). 1999;13(Pt 3a):374–376. 2000/01/07. doi:10.1038/eye.1999.96.
   PubMedGoogle Scholar
• Matlach J, Freiberg FJ, Gadeholt O, Göbel W. Vasculitis-like hemorrhagic retinal angiopathy in Wegener’s granulomatosis. BMC Res Notes. September 09, 2013;6:364. doi:10.1186/1756-0500-6-364.
   PubMedGoogle Scholar
• Janknecht P, Mittelviefhaus H, Loffler KU. Sclerochoroidal granuloma in Wegener’s granulomatosis simulating a uveal melanoma. Retina. January 01, 1995;15:150–153. doi:10.1097/00006982-199515020-00011.
   PubMed Web of Science ®Google Scholar
• Wang M, Khurana RN, Sadda SR. Central retinal vein occlusion in Wegener’s granulomatosis without retinal vasculitis. Br J Ophthalmol. October 24, 2006;90:1435–1436. doi:10.1136/bjo.2006.095703.
   PubMed Web of Science ®Google Scholar
• Pulido JS, Goeken JA, Nerad JA, Sobol WM, Folberg R. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies. Arch Ophthalmol. June 01, 1990;108:845–850. doi:10.1001/archopht.1990.01070080087041.
   PubMedGoogle Scholar
• Wong SC, Boyce RL, Dowd TC, Fordham JN. Bilateral central retinal artery occlusion in Wegener’s granulomatosis and alpha(1) antitrypsin deficiency. Br J Ophthalmol. March 27, 2002;86:476. doi:10.1136/bjo.86.4.476.
   PubMed Web of Science ®Google Scholar
• Macarie SS, Kadar A. Eye involvement in ANCA positive vasculitis. Rom J Ophthalmol. January-March, 2020;64(1):3–7. doi:10.22336/rjo.2020.2.
   PubMedGoogle Scholar
• Isik MU, Yalcindag N. Comparison of spectral domain optical coherence tomography (SD OCT) Findings with Laser Flare Photometry (LFP) Measurements in Behcet’s Uveitis. Ocul Immunol Inflamm. 2020;28:194–199. 2018/12/18. doi:10.1080/09273948.2018.1552976.
   PubMed Web of Science ®Google Scholar
• Comez A, Beyoglu A, Karakucuk Y. Quantitative analysis of retinal microcirculation in optical coherence tomography angiography in cases with Behcet’s disease without ocular involvement. Int Ophthalmol. March 16, 2019;39:2213–2221. doi:10.1007/s10792-018-1059-z.
   PubMed Web of Science ®Google Scholar
• Akmaz B, Akay F, Isik MU, et al. Retinal and choroidal vascular structures are affected in axial spondyloarthritis: an optical coherence tomography study. Int Ophthalmol. April 25, 2020;40:1977–1986. doi:10.1007/s10792-020-01372-x.
   PubMed Web of Science ®Google Scholar
• Akay F, Akmaz B, Işik MU, Güven YZ, Örük GG. Evaluation of the retinal layers and microvasculature in patients with acromegaly: a case-control OCT angiography study. Eye. 2020;35:523–527. doi:10.1038/s41433-020-0884-2.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827–1832. 2008/12/05. doi:10.1136/ard.2008.101279.
   PubMed Web of Science ®Google Scholar
• Exley AR, Bacon PA, Luqmani RA, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. February 01, 1997;40:371–380. doi:10.1002/art.1780400222.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Chen CL, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. August 02, 2017;60:66–100. doi:10.1016/j.preteyeres.2017.07.002.
   PubMed Web of Science ®Google Scholar
• Sehi M, Goharian I, Konduru R, et al. Retinal blood flow in glaucomatous eyes with single-hemifield damage. Ophthalmology. 2014;121:750–758. 2013/12/03. doi:10.1016/j.ophtha.2013.10.022.
   PubMed Web of Science ®Google Scholar
• Anraku A, Ishida K, Enomoto N, et al. Association between Optic Nerve Head Microcirculation and Macular Ganglion Cell Complex Thickness in Eyes with Untreated Normal Tension Glaucoma and a Hemifield Defect. J Ophthalmol. April 21, 2017;2017:3608396. doi:10.1155/2017/3608396.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. October 01, 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Lin M, Anesi SD, Ma L, Ahmed A, Small K, Foster CS. Characteristics and Visual Outcome of Refractory Retinal Vasculitis Associated With Antineutrophil Cytoplasm Antibody-Associated Vasculitides. Am J Ophthalmol. 2018;187:21–33. 2017/12/21. doi:10.1016/j.ajo.2017.12.004.
   PubMed Web of Science ®Google Scholar
• Jarrot PA, Kaplanski G. Pathogenesis of ANCA-associated vasculitis: an update. Autoimmun Rev. March 13, 2016;15:704–713. doi:10.1016/j.autrev.2016.03.007.
   PubMed Web of Science ®Google Scholar
• Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol. November 30, 2006;2:661–670. doi:10.1038/ncprheum0355.
   PubMedGoogle Scholar
• Khairallah M, Abroug N, Khochtali S, et al. Optical Coherence Tomography Angiography in Patients with Behcet Uveitis. Retina. 2017;37:1678–1691. 2016/12/22. doi:10.1097/IAE.0000000000001418.
   PubMed Web of Science ®Google Scholar
• Spaide RF. MICROVASCULAR FLOW ABNORMALITIES ASSOCIATED WITH RETINAL VASCULITIS: a Potential of Mechanism of Retinal Injury. Retina. 2017;37:1034–1042. 2016/10/21. doi:10.1097/IAE.0000000000001359.
   PubMed Web of Science ®Google Scholar
• Merkel PA, Aydin SZ, Boers M, et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol. July 05, 2011;38:1480–1486. doi:10.3899/jrheum.110276.
   PubMed Web of Science ®Google Scholar